Search

John D. Pak

Examiner (ID: 48)

Most Active Art Unit
1616
Art Unit(s)
1699, 2899, 1209, 1616, 1621
Total Applications
2727
Issued Applications
1512
Pending Applications
257
Abandoned Applications
978

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11033232 [patent_doc_number] => 20160230189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-11 [patent_title] => 'NANOPARTICLE-MEDIATED GENE DELIVERY, GENOMIC EDITING AND LIGAND-TARGETED MODIFICATION IN VARIOUS CELL POPULATIONS' [patent_app_type] => utility [patent_app_number] => 15/024264 [patent_app_country] => US [patent_app_date] => 2014-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 7239 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15024264 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/024264
Nanoparticle-mediated gene delivery, genomic editing and ligand-targeted modification in various cell populations Sep 22, 2014 Issued
Array ( [id] => 10312739 [patent_doc_number] => 20150197741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-16 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATMENT OF TRAUMATIC BRAIN INJURY AND FOR MODULATION OF MIGRATION OF NEUROGENIC CELLS' [patent_app_type] => utility [patent_app_number] => 14/489934 [patent_app_country] => US [patent_app_date] => 2014-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9971 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14489934 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/489934
METHODS AND COMPOSITIONS FOR TREATMENT OF TRAUMATIC BRAIN INJURY AND FOR MODULATION OF MIGRATION OF NEUROGENIC CELLS Sep 17, 2014 Abandoned
Array ( [id] => 10317325 [patent_doc_number] => 20150202328 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2015-07-23 [patent_title] => 'ARTIFICIAL LIPID-POLYMER-DNA COMPLEX, BIOIMAGING AGENT AND PREPARATION METHOD THEREOF' [patent_app_type] => utility [patent_app_number] => 14/466635 [patent_app_country] => US [patent_app_date] => 2014-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 5925 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14466635 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/466635
ARTIFICIAL LIPID-POLYMER-DNA COMPLEX, BIOIMAGING AGENT AND PREPARATION METHOD THEREOF Aug 21, 2014 Abandoned
Array ( [id] => 10317325 [patent_doc_number] => 20150202328 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2015-07-23 [patent_title] => 'ARTIFICIAL LIPID-POLYMER-DNA COMPLEX, BIOIMAGING AGENT AND PREPARATION METHOD THEREOF' [patent_app_type] => utility [patent_app_number] => 14/466635 [patent_app_country] => US [patent_app_date] => 2014-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 5925 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14466635 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/466635
ARTIFICIAL LIPID-POLYMER-DNA COMPLEX, BIOIMAGING AGENT AND PREPARATION METHOD THEREOF Aug 21, 2014 Abandoned
Array ( [id] => 11778215 [patent_doc_number] => 09387251 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-12 [patent_title] => 'Sugar alcohol-based compositions for delivering nucleic acid-based drugs in vivo and in vitro' [patent_app_type] => utility [patent_app_number] => 14/457829 [patent_app_country] => US [patent_app_date] => 2014-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 10402 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 198 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14457829 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/457829
Sugar alcohol-based compositions for delivering nucleic acid-based drugs in vivo and in vitro Aug 11, 2014 Issued
Array ( [id] => 12566475 [patent_doc_number] => 10017734 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-10 [patent_title] => Method for producing dopaminergic neurons [patent_app_type] => utility [patent_app_number] => 14/910018 [patent_app_country] => US [patent_app_date] => 2014-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 17 [patent_no_of_words] => 13577 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14910018 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/910018
Method for producing dopaminergic neurons Aug 5, 2014 Issued
Array ( [id] => 10925906 [patent_doc_number] => 20140328927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-06 [patent_title] => 'ANTI-CANCER NANOPARTICLE COMPOSITIONS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 14/336492 [patent_app_country] => US [patent_app_date] => 2014-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10386 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14336492 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/336492
Anti-cancer nanoparticle compositions and methods of use Jul 20, 2014 Issued
Array ( [id] => 10756172 [patent_doc_number] => 20160102324 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-14 [patent_title] => 'NEW COMPACT SCAFFOLD OF CAS9 IN THE TYPE II CRISPR SYSTEM' [patent_app_type] => utility [patent_app_number] => 14/892707 [patent_app_country] => US [patent_app_date] => 2014-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16825 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14892707 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/892707
Compact scaffold of Cas9 in the type II CRISPR system May 27, 2014 Issued
Array ( [id] => 9699522 [patent_doc_number] => 20140249207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-04 [patent_title] => 'MEANS FOR INHIBITING THE EXPRESSION OF ORC-1' [patent_app_type] => utility [patent_app_number] => 14/274991 [patent_app_country] => US [patent_app_date] => 2014-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 27760 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14274991 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/274991
MEANS FOR INHIBITING THE EXPRESSION OF ORC-1 May 11, 2014 Abandoned
Array ( [id] => 10729902 [patent_doc_number] => 20160076051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-17 [patent_title] => 'Expression Process' [patent_app_type] => utility [patent_app_number] => 14/787669 [patent_app_country] => US [patent_app_date] => 2014-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3813 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14787669 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/787669
Expression process Apr 28, 2014 Issued
Array ( [id] => 10940111 [patent_doc_number] => 20140343132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'GENE EXPRESSION AND PAIN' [patent_app_type] => utility [patent_app_number] => 14/258927 [patent_app_country] => US [patent_app_date] => 2014-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 32762 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14258927 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/258927
Gene expression and pain Apr 21, 2014 Issued
Array ( [id] => 9643108 [patent_doc_number] => 20140221220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-07 [patent_title] => 'METHOD OF MEASURING ADAPTIVE IMMUNITY' [patent_app_type] => utility [patent_app_number] => 14/252189 [patent_app_country] => US [patent_app_date] => 2014-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13334 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14252189 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/252189
METHOD OF MEASURING ADAPTIVE IMMUNITY Apr 13, 2014 Abandoned
Array ( [id] => 9635354 [patent_doc_number] => 20140213463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-31 [patent_title] => 'Method of Measuring Adaptive Immunity' [patent_app_type] => utility [patent_app_number] => 14/243875 [patent_app_country] => US [patent_app_date] => 2014-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13322 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14243875 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/243875
Method of Measuring Adaptive Immunity Apr 1, 2014 Abandoned
Array ( [id] => 9720865 [patent_doc_number] => 20140256567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'Method of Measuring Adaptive Immunity' [patent_app_type] => utility [patent_app_number] => 14/242299 [patent_app_country] => US [patent_app_date] => 2014-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13379 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14242299 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/242299
Method of Measuring Adaptive Immunity Mar 31, 2014 Abandoned
Array ( [id] => 10181675 [patent_doc_number] => 09211339 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-15 [patent_title] => 'Compositions for delivery of cargo such as drugs proteins and/or genetic materials' [patent_app_type] => utility [patent_app_number] => 14/230986 [patent_app_country] => US [patent_app_date] => 2014-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 20 [patent_no_of_words] => 15818 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14230986 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/230986
Compositions for delivery of cargo such as drugs proteins and/or genetic materials Mar 30, 2014 Issued
Array ( [id] => 9616202 [patent_doc_number] => 20140206059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-24 [patent_title] => 'Transcriptome Transfer Produces Cellular Phenotype Conversion' [patent_app_type] => utility [patent_app_number] => 14/230848 [patent_app_country] => US [patent_app_date] => 2014-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 20396 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14230848 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/230848
Transcriptome transfer produces cellular phenotype conversion Mar 30, 2014 Issued
Array ( [id] => 10705553 [patent_doc_number] => 20160051700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-25 [patent_title] => 'SYSTEMS AND METHODS FOR THE TARGETED PRODUCTION OF A THERAPEUTIC PROTEIN WITHIN A TARGET CELL' [patent_app_type] => utility [patent_app_number] => 14/779565 [patent_app_country] => US [patent_app_date] => 2014-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15398 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14779565 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/779565
SYSTEMS AND METHODS FOR THE TARGETED PRODUCTION OF A THERAPEUTIC PROTEIN WITHIN A TARGET CELL Mar 23, 2014 Abandoned
Array ( [id] => 9603080 [patent_doc_number] => 20140199761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-17 [patent_title] => 'PROMOTER-REGULATED DIFFERENTIATION-DEPENDENT SELF-DELETING CASSETTE' [patent_app_type] => utility [patent_app_number] => 14/218284 [patent_app_country] => US [patent_app_date] => 2014-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13545 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14218284 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/218284
PROMOTER-REGULATED DIFFERENTIATION-DEPENDENT SELF-DELETING CASSETTE Mar 17, 2014 Abandoned
Array ( [id] => 9602694 [patent_doc_number] => 20140199377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-17 [patent_title] => 'MULTIPLE GROWTH FACTOR COMPOSITIONS, METHODS OF FABRICATION, AND METHODS OF TREATMENT' [patent_app_type] => utility [patent_app_number] => 14/218279 [patent_app_country] => US [patent_app_date] => 2014-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7508 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14218279 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/218279
MULTIPLE GROWTH FACTOR COMPOSITIONS, METHODS OF FABRICATION, AND METHODS OF TREATMENT Mar 17, 2014 Abandoned
Array ( [id] => 10700575 [patent_doc_number] => 20160046722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-18 [patent_title] => 'NOVEL MEDICAMENTS COMPRISING AN ANTIBODY COMPOSITION ENRICHED WITH PREDOMINANT CHARGE ISOFORM' [patent_app_type] => utility [patent_app_number] => 14/776725 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17931 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776725 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/776725
NOVEL MEDICAMENTS COMPRISING AN ANTIBODY COMPOSITION ENRICHED WITH PREDOMINANT CHARGE ISOFORM Mar 13, 2014 Abandoned
Menu